Safety Alert

# Title Type of news Date Link of news
228 Safety Signals Identified by SFDA (October - December) 2025 Signal
227 Safety Signal of Onasemnogene Abeparvovec and the Risk of Pneumonia Signal
226 Safety Signal of Liraglutide and the Risk of Hepatocellular Carcinoma Signal
225 Safety Signal of Dulaglutide and the Risk of Sleep Disorder Signal
224 Safety Signal of Desogestrel and the Risk of Meningioma Signal
223 Safety Signal of Daratumumab and the Risk of Conjunctivitis Signal
222 Safety Signal of Baricitinib and the Risk of Fracture Signal
221 Safety Signal of Exenatide and the Risk of Hepatocellular Carcinoma Signal
220 Safety Signals Identified by SFDA (July - September) 2025 Signal
219 Safety Signal of Cytarabine and the Risk of Palmar plantar erythrodysaesthesia syndrome Signal
Displaying 1 - 10 of 230